Author:
Cheng Adrian S.H.,Selvanayagam Joseph B.
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine
Reference93 articles.
1. Imaging artifacts at 3.0T;Bernstein;J Magn Reson Imaging,2006
2. U.S. Food and Drug Administration. Guidance for Industry and FDA Staff: Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. 2003. Accessed 20th Nov 2009, at http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm072688.pdf.
3. Comprehensive cardiac magnetic resonance imaging at 3.0Tesla: feasibility and implications for clinical applications;Gutberlet;Invest Radiol,2006
4. 3.0 T cardiovascular magnetic resonance in patients treated with coronary stenting for myocardial infarction: evaluation of short term safety and image quality;Nijveldt;Int J Cardiovasc Imaging,2008
5. Biomedical implants and devices: assessment of magnetic field interactions with a 3.0-Tesla MR system;Shellock;J Magn Reson Imaging,2002
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献